Results analysis from Kepler Trust Intelligence

Summary by AI BETAClose X

Ashoka India Equity Investment Trust reported its annual results for the year ending June 30, 2026, achieving a net asset value total return of -5.9%, outperforming its benchmark, the MSCI India IMI Index, which returned -8.5%. Despite a recent discount of 4.2% on its shares, the trust has delivered strong long-term returns of 164% since inception in July 2018, more than double the benchmark's 76%. Positive stock selection contributed to performance, with top performers like TD Power Systems, Acutaas Chemicals, and Aditya Infotech seeing significant share price increases, while OneSource Specialty Pharma, Info Edge, and Bharti Airtel were key detractors. The trust also experienced share redemptions totaling 5.5% of its issued shares in September 2026.

Disclaimer*

Ashoka India Equity Investment Tst
09 October 2026
 

Ashoka India Equity

09/10/2026

Results analysis from Kepler Trust Intelligence

Ashoka India Equity (AIE) has released its annual results for the year ending 30/06/2026, with another year of outperformance of its benchmark, the MSCI India IMI Index, delivering a NAV total return of -5.9%, versus -8.5% for the index. We note the index return does not account for local capital gains taxation, in contrast to AIE's NAV.

Despite the near-term pullback, long-term returns remain very strong, with returns since inception in July 2018 of 164%, more than double the 76% of the benchmark.

Stock selection continued to be positive in the year, with a broad range of stocks supporting performance and the top three contributors seeing their share prices more than double over the period. This was led by air-conditioning company TD Power Systems, which saw greater industrial demand, followed by Acutaas Chemicals, which contributed positively after seeing upgraded guidance on good revenue growth, with video and surveillance firm Aditya Infotech completing the top three with better-than-expected operating performance. 

Detractors were equally diverse, with healthcare manufacturer OneSource Specialty Pharma, recruitment firm Info Edge, and telecoms firm Bharti Airtel being the three biggest impacts on performance.

The trust's rating moved to a discount throughout the year, closing at 4.2%. This contrasts with the premium rating for much of its history, including at the start of the financial year, which enabled 1.1m shares to be issued over the 12-month period.

The trust also has an annual redemption facility, with requests for 9.4m shares, or 5.5% of total shares in issue, received in September 2026.

Kepler View

Whilst returns in absolute terms may not compete with some of the blockbuster numbers of previous financial years, we believe yet another year of outperformance should provide encouragement to Ashoka India Equity's (AIE) shareholders. The outperformance is particularly notable given the management team's focus on small and mid-sized companies amidst the backdrop of falling markets which is typically less supportive of the asset class.

The period is also a reminder that, despite the numerous positive factors in favour of the Indian growth story, that markets don't go up in a straight line. However, with a NAV total return that is more than double that of the index since inception, the managers have demonstrated an ability to produce strong relative performance in a variety of environments, making the trust a very strong contender as a long-term holding in our view.

Whilst the investing environment has been more challenging, the managers highlight several key factors that could indicate the country is on the cusp of a recovery. Corporate earnings are showing early signs of a pickup, with double-digit growth, with smaller companies nearing 20%. Meanwhile, the pullback has led to a softening of valuations, with the Indian market now trading at a discount to its 10-year average on a forward price-to-earnings basis. Meanwhile, the wider economy has shown good resilience, weathering the headwinds to deliver an expected GDP growth of over 6.5% next year, a figure double what most developed economies would be delighted with.

CLICK HERE TO READ THE FULL REPORT 

Visit Kepler Trust Intelligence for more high quality independent investment trust research.

Important information

This report has been issued by Kepler Partners LLP.  The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.  

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings